Get the Stockscreener App
5.37
4.28%
-0.24
Pre-market:
5.42
0.05
+0.93%
Certara Inc stock is traded at $5.37, with a volume of 4.85M.
It is down -4.28% in the last 24 hours and down -13.11% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$5.61
Open:
$5.56
24h Volume:
4.85M
Relative Volume:
1.25
Market Cap:
$835.38M
Revenue:
$418.84M
Net Income/Loss:
$-1.60M
P/E Ratio:
-521.36
EPS:
-0.0103
Net Cash Flow:
$69.77M
1W Performance:
-7.73%
1M Performance:
-13.11%
6M Performance:
-41.76%
1Y Performance:
-54.10%
1-Day Range:
$5.295
$5.77
1-Week Range:
$5.295
$6.165
52-Week Range:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
5.37 | 872.72M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
172.61 | 29.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
57.40 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.43 | 9.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.67 | 7.19B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
63.62 | 4.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference - Yahoo Finance
Certara Inc stock (US1567671046): Shares under pressure after investigation headlines - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Certara, Inc. (CERT) And Encourages Shareholders to Reach Out | NDAQ:CERT | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
How Certara (CERT) Investors Can Read The Quiet Shift In The Valuation Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Shareholders to Learn More About the Investigation | NDAQ:CERT | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
Barclays downgrades Certara stock rating on turnaround concerns - Investing.com
CERT Technical Analysis & Stock Price Forecast - Intellectia AI
Certara, Inc. Stock Hits Day Low of $5.55 Amid Price Pressure - MarketsMojo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Certara Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Do Options Traders Know Something About Certara Stock We Don't? - MSN
Certara (CERT) CHRO nets shares from RSU vesting and tax withholding - Stock Titan
Certara (CERT) SVP Daniel Corcoran exercises RSUs; 12,103 shares withheld for taxes - Stock Titan
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT - The National Law Review
Is Now An Opportune Moment To Examine Certara, Inc. (NASDAQ:CERT)? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Certara, Inc. (CERT) And Encourages Investors to Connect - ACCESS Newswire
Certara Inc stock (US1567671046): Q1 2026 services slowdown and investor lawsuit probe keep focus on - AD HOC NEWS
Certara (CERT) shares slide after weak full-year guidance overshadows revenue beat - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Certara Inc stock (US1567671046): shares slip after Q1 2026 revenue mix and legal probe headline - AD HOC NEWS
(CERT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Certara says AI investments will drive long-term growth – but traders are focused on one warning - MSN
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Investors to Inquire about Securities Investigation - ACCESS Newswire
CERT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - Caledonian Record
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
EDGAR Filing Documents for 0001827090-23-000010 - SEC.gov
Certara, Inc. (CERT) Q1 earnings miss estimates - MSN
Certara shares drop 19% after Q1 revenue decline and management inconsistency concerns. - Pluang
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Certara, Inc. (CERT) And Encourages Investors to Reach Out - ACCESS Newswire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire
Certara’s SWOT analysis: life sciences stock faces leadership shift By Investing.com - Investing.com Australia
Certara’s SWOT analysis: life sciences stock faces leadership shift - Investing.com
Certara to Participate in Upcoming Investor Conferences - The Manila Times
Certara schedules RBC, William Blair and Jefferies investor appearances - Stock Titan
Certara expects $395M-$405M 2026 revenue following medical writing divestiture - MSN
Certara's US$101m Market Cap Fall Books Insider Losses - 富途牛牛
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
Jun 01 '26 |
Option Exercise |
0.00 |
22,830 |
0 |
39,939 |
| Collins Cynthia | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
| Resnick Jon Matthew | Chief Executive Officer |
May 11 '26 |
Option Exercise |
0.00 |
59,766 |
0 |
59,766 |
2.46%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):